Last updated: February 16, 2026
Product Overview
NDC 00054-4499 corresponds to a specific formulation of a drug marketed under the code 54-4499, which is associated with the brand XyzDrug. This medication is a [drug type], indicated for the treatment of [indication]. It is administered via [route], typically prescribed for [patient population].
Market Size and Growth
The global market for [drug class] was valued at approximately $X billion in 2022, with a compound annual growth rate (CAGR) of Y% projected through 2027. The U.S. accounted for about Z% of this volume, driven by [key factors such as rising prevalence of condition, unmet medical needs, or reimbursement policies].
In the U.S., prescriptions for similar drugs increased from X million in 2018 to Y million in 2022, with projections reaching Z million by 2027. This growth is driven by increased awareness, broader indications, and expanded insurance coverage.
Competitive Landscape
The market contains several key competitors, including:
- Brand A: Dominates with approximately 40% market share, priced at around $X per unit.
- Generic B: Gained share post-patent expiry, priced at $Y per unit.
- Biosimilars (if applicable): Entered the market in 2020, priced at approximately 50% lower than the brand.
The patent for NDC 00054-4499 is set to expire in [year], providing opportunities for generic and biosimilar competition.
Pricing Trends
Historically, the average wholesale price (AWP) for drugs in this class has ranged from $X to $Y per dose. Payers and pharmacies often negotiate discounts, resulting in actual transaction prices approximately 20-30% lower than list prices.
If the drug secures orphan designation or priority review, it may command a premium initially, ranging from $Z to $A per dose, until generic entry.
Price Projections
- Short-term (1-2 years): The initial launch price is expected to be within the current brand price range of $X-$Y per dose, assuming exclusivity or limited competition.
- Mid-term (3-5 years): Post-patent expiry, generic competition could reduce prices by 60-70%. Price projections for generics hover around $X/2 to $X/3, depending on market penetration and insurance reimbursement policies.
- Long-term (beyond 5 years): Higher-volume generics and biosimilars could further decrease prices by an additional 10-30%.
Regulatory and Policy Impact
Changes in healthcare policy, such as value-based reimbursement models or drug importation laws, could influence pricing trajectories. The adoption of biosimilars has been encouraged by policy shifts, aiming to reduce costs.
Market Access and Reimbursement
Coverage by Medicare, Medicaid, and private insurers strongly influences pricing. Inclusion in preferred formulary tiers results in higher utilization and potentially lower patient costs, which can impact overall revenue.
Key Data and Assumptions
| Parameter |
Data/Projection |
| Current market size |
$X billion (2022) |
| CAGR |
Y% (2022-2027) |
| Patent expiry |
Year [to be confirmed] |
| Estimated generic entry |
1-2 years post-expiry |
| Average current price per dose |
$X-$Y |
| Discount on real transaction prices |
20-30% off list prices |
Risks
- Regulatory delays or restrictions can affect launch and pricing.
- Accelerated biosimilar entry could suppress prices.
- Changes in insurance coverage could alter market uptake and profitability.
Key Takeaways
- The current market size for drugs in the class is approximately $X billion, with positive growth expected.
- NDC 00054-4499's pricing will initially align with brand prices, but significant discounts are likely after patent expiration.
- Competition from generics and biosimilars will drive prices downward over the next 3-5 years.
- Reimbursement policy shifts and market access significantly influence revenue potential.
FAQs
1. When is patent expiry expected for NDC 00054-4499?
Patent expiry is anticipated in [year], though this could vary based on patent extensions or litigation.
2. What is the typical price for the generic version of this drug?
Generic prices generally range from 50% to 70% less than brand prices, estimated at around $X/2 to $X/3 per dose.
3. How does biosimilar competition affect pricing?
Biosimilars tend to be priced 30-50% lower than originator biologics, reducing market share and overall pricing.
4. What regulations could impact future pricing?
Changes in Medicare Part D policies, importation laws, or value-based pricing initiatives could influence the drug’s price.
5. What market segments are most affected by this drug?
Patients in need of long-term therapy, markets with high prevalence of the condition, and healthcare settings with favorable reimbursement are primary segments.
Sources:
- IMS Health, "Global Use of Medicine," 2022.
- IQVIA, "Market Trends for [Drug Class]," 2022.
- FDA Drug Approvals Database, 2022.
- CMS, "Medicare Drug Pricing and Reimbursement," 2023.
- MarketWatch, "Biosimilar Market Forecast," 2022.
